Melodiol Global Health Limited

Results For Announcement To The Market For The Half-Year Ended 30 June 2023

Melodiol Global Health Limited (ASX:ME1, FRA:1X8) (‘Melodiol’ or ‘the Company’) is pleased to present its Half Year Report.


Click here for the full ASX Release

This article includes content from Melodial Global Health, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

The Conversation (0)
Melodiol Global Health

Melodiol Global Health

Global Portfolio of Strategic Cannabis and Plant-based Businesses

Global Portfolio of Strategic Cannabis and Plant-based Businesses Keep Reading...

Interactive Chart

Latest Press Releases

Related News